Here is my review.

Summary
- The paper proposes TimeWarn, an interpretable, time-aware extension of RETAIN that modulates both visit-level and variable-level attention by learned exponential decays based on time since last measurement. 
- Evaluated on MIMIC-IV and eICU, TimeWarn achieves consistent improvements over strong baselines (including GRU-D and RETAIN) for 6-hour-ahead sepsis prediction, with modest but consistent AUROC/AUPRC gains. 
- An ablation suggests the time-decay is a key contributor, and attention analyses align with clinical expectations (e.g., lactate, respiratory rate).

Strengths
- Clear problem motivation: irregular sampling in EHRs is crucial for early sepsis prediction.
- Sensible, lightweight extension of an interpretable architecture; preserves clinical interpretability.
- Strong baselines included (qSOFA, LR, XGBoost, GRU-D, RETAIN); multi-dataset evaluation with multiple seeds; reporting AUROC and AUPRC.
- Improvements are consistent across datasets and horizons (6h, 12h).
- Ablation study indicates the contribution of time decay; analysis of attention weights is clinically plausible.

Concerns and suggestions
- Fairness of comparison: TimeWarn is tuned via grid search (72 configs), while baselines rely on hyperparameters from original papers. This may understate baseline performance. Please tune baselines on validation sets for parity.
- Methodological clarity: After multiplying attention weights by the decay γ, are the attention weights renormalized (e.g., via softmax) at either level? If not, interpretability as a probability simplex is lost and scale can drift; if yes, please state explicitly.
- Related work coverage: There is prior art on time-aware attention and irregularity handling beyond RETAIN and GRU-D (e.g., T-LSTM, AdaCare, HiTANet, time-aware/elapsed-time attention variants). Position TimeWarn more precisely relative to these to clarify novelty.
- Calibration and operating points: For deployment, calibration metrics and sensitivity/PPV at clinically relevant thresholds would be helpful. 
- Labeling and leakage: Clarify safeguards against label leakage around the sepsis onset window (e.g., exclusion of post-onset features or proxies like post-onset antibiotics).
- Reproducibility: Consider releasing code and exact feature engineering details (embedding formulation, missingness handling, normalization strategies).

Scores (0–100)
- Soundness: 82
  - Method is reasonable and supported by ablation; a few methodological details need clarification, and comparison fairness can be improved.
- Novelty: 68
  - Incremental extension of RETAIN with GRU-D–like decay; novelty mainly in modulating both attention levels with learned per-variable decay.
- Significance: 78
  - Sepsis prediction is impactful; improvements are consistent though modest; interpretability is a plus for clinical adoption.
- Clarity: 88
  - Well-written and easy to follow; would benefit from more implementation details and broader related work discussion.

Final average score
- (82 + 68 + 78 + 88) / 4 = 79.0

Recommendation
- Accept

Rationale: Despite incremental novelty and some comparison fairness issues, the work is solid, improves over strong baselines across two public datasets, preserves interpretability, and addresses an important practical gap (irregular sampling) with a simple, effective mechanism. The concerns are addressable in a camera-ready revision.